Isolated polycystic liver disease genes define effectors of polycystin-1 function
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Dominantly inherited isolated polycystic liver disease (PCLD) consists of liver cysts that are radiologically and pathologically identical to those seen in autosomal dominant polycystic kidney disease, but without clinically relevant kidney cysts. The causative genes are known for fewer than 40% of PCLD index cases. Here, we have used whole exome sequencing in a discovery cohort of 102 unrelated patients who were excluded for mutations in the 2 most common PCLD genes, PRKCSH and SEC63, to identify heterozygous loss-of-function mutations in 3 additional genes, ALG8, GANAB, and SEC61B. Similarly to PRKCSH and SEC63, these genes encode proteins that are integral to the protein biogenesis pathway in the endoplasmic reticulum. We inactivated these candidate genes in cell line models to show that loss of function of each results in defective maturation and trafficking of polycystin-1, the central determinant of cyst pathogenesis. Despite acting in a common pathway, each PCLD gene product demonstrated distinct effects on polycystin-1 biogenesis. We also found enrichment on a genome-wide basis of heterozygous mutations in the autosomal recessive polycystic kidney disease gene PKHD1, indicating that adult PKHD1 carriers can present with clinical PCLD. These findings define genetic and biochemical modulators of polycystin-1 function and provide a more complete definition of the spectrum of dominant human polycystic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Once OST catalyzes the attachment of the glycan moiety to asparagine residues, first, GI removes the outermost glucose residue, and then GII removes the second one, as expected [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, mutations in SEC63 and PRKCSH are known to cause PCLD, also reducing directly the working dosage of PC1 in the bile duct and kidney tubules cells [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, SEC63 and ERdj1 act in relation to chaperone BiP, facilitating this translocation process.”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Once OST catalyzes the attachment of the glycan moiety to asparagine residues, first, GI removes the outermost glucose residue, and then GII removes the second one, as expected [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, the loss of Sec61b, Sec63 and PRKCSH results in a severe deficiency of PC1; Alg8 knockout causes the hypoglycosylation of PC1; GANAB knockout results in a defective glucose trimming of N-glycan moieties, resulting in increased apparent molecular mass for PC1 [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Browning, S. R., & Browning, B. L. (2007) · The American Journal of Human Genetics · doi:10.1086/521987 · Cited by 3,210
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Self-citation
Cited by
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationAutosomal dominant polycystic kidney disease
Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32782-x · Cited by 624
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases
Cornec-Le Gall, E., Torres, V. E., & Harris, P. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017050483 · Cited by 406
Self-citationMonoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease
Cornec-Le Gall, E., Olson, R. J., Besse, W., Heyer, C. M., Gainullin, V. G., Smith, J. M., Audrézet, M.-P., Hopp, K., Porath, B., Shi, B., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.013 · Cited by 312
Self-citationPrevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing
Lanktree, M. B., Haghighi, A., Guiard, E., Iliuta, I.-A., Song, X., Harris, P. C., Paterson, A. D., & Pei, Y. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018050493 · Cited by 300
Self-citationA Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
Chebib, F. T., Perrone, R. D., Chapman, A. B., Dahl, N. K., Harris, P. C., Mrug, M., Mustafa, R. A., Rastogi, A., Watnick, T., Yu, A. S. L., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018060590 · Cited by 257
Self-citationDevuyst, O., Ahn, C., Barten, T. R. M., Brosnahan, G., Cadnapaphornchai, M. A., Chapman, A. B., Gall, É. C.-L., Drenth, J. P. H., Gansevoort, R. T., Harris, P. C., et al. (2025) · Kidney International · doi:10.1016/j.kint.2024.07.009 · Cited by 179
Self-citationSenum, S. R., Li, Y. (. M., Benson, K. A., Joli, G., Olinger, E., Lavu, S., Madsen, C. D., Gregory, A. V., Neatu, R., Kline, T. L., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.016 · Cited by 174
Self-citationClinical management of polycystic liver disease
van Aerts, R. M. M., van de Laarschot, L. F. M., Banales, J. M., & Drenth, J. P. H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.024 · Cited by 173
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies
Lanktree, M. B., Haghighi, A., di Bari, I., Song, X., & Pei, Y. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02320220 · Cited by 169
Self-citationAn Update on Sec61 Channel Functions, Mechanisms, and Related Diseases
Lang, S., Pfeffer, S., Lee, P.-H., Cavalié, A., Helms, V., Förster, F., & Zimmermann, R. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00887 · Cited by 159
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases
Fabris, L., Fiorotto, R., Spirlì, C., Cadamuro, M., Mariotti, V., Perugorria, M. J., Bañales, J. M., & Strazzabosco, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0156-4 · Cited by 127
Autosomal Dominant Polycystic Kidney Disease: A Review
Chebib, F. T., Hanna, C., Harris, P. C., Torres, V. E., & Dahl, N. K. (2025) · JAMA · doi:10.1001/jama.2025.0310 · Cited by 101
Self-citationExome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease
Chang, A. R., Moore, B. S., Luo, J. Z., Sartori, G., Fang, B., Jacobs, S., Abdalla, Y., Taher, M., Carey, D. J., Triffo, W. J., et al. (2022) · JAMA · doi:10.1001/jama.2022.22847 · Cited by 97
Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management
Zhang, Z., Wang, Z., & Huang, Y. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i3.72 · Cited by 92
Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease
Huynh, V. T., Audrézet, M., Sayer, J. A., Ong, A. C. M., Lefèvre, S., Brun, V. L., Després, A., Senum, S. R., Chebib, F. T., Barroso‐Gil, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.02.022 · Cited by 89
New treatment paradigms for ADPKD: moving towards precision medicine
Lanktree, M. B., & Chapman, A. B. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.127 · Cited by 88
Lemoine, H., Raud, L., Foulquier, F., Sayer, J. A., Lambert, B., Olinger, E. G., Lefèvre, S., Knebelmann, B., Harris, P. C., Trouvé, P., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.06.013 · Cited by 86
Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation
Durán, D., Zeng, X. Q., Jin, S. C., Choi, J., Nelson-Williams, C. J., Yatsula, B. A., Gaillard, J. R., Furey, C. G., Lu, Q., Timberlake, A. T., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.11.041 · Cited by 81
Self-citationCilia and polycystic kidney disease
Ma, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.05.003 · Cited by 78
Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County
Suwabe, T., Shukoor, S., Chamberlain, A. M., Killian, J. M., King, B. F., Edwards, M. E., Senum, S. R., Madsen, C. D., Chebib, F. T., Hogan, M. C., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05900519 · Cited by 65
Self-citationHu, C. W., Xin, Z., Sun, X., Hu, Y., Zhang, C., Yan, R., Wang, Y., Lu, M., Huang, J., Du, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02656-7 · Cited by 63
Contributions of Rare Gene Variants to Familial and Sporadic FSGS
Wang, M., Chun, J., Genovese, G., Knob, A. U., Benjamin, A., Wilkins, M. S., Friedman, D. J., Appel, G. B., Lifton, R. P., Mane, S., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020152 · Cited by 62
Self-citationCordido, A., Cerecedo, L. B., & García-González, M. Á. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00279 · Cited by 60
Olson, R. J., Hopp, K., Wells, H. H., Smith, J. M., Furtado, J., Constans, M., Escobar-Zarate, D., Geurts, A. M., Torres, V. E., & Harris, P. C. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020150 · Cited by 58
Self-citationPhysiologic mechanisms underlying polycystic kidney disease
Boletta, A., & Caplan, M. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00018.2024 · Cited by 57
Onuchic, L., Padovano, V., Schena, G., Rajendran, V., Dong, K., Shi, X., Pandya, R. D., Rai, V., Gresko, N., Ahmed, O., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37449-1 · Cited by 57
Self-citationExome-Based Rare-Variant Analyses in CKD
Cameron‐Christie, S., Wolock, C. J., Groopman, E., Petrovski, S., Kamalakaran, S., Povysil, G., Vitsios, D., Zhang, M., Fleckner, J., March, R. E., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018090909 · Cited by 56
Self-citationKrálovičová, J., Borovská, I., Stejskalová, E., Obuća, M., Hiller, M., Staněk, D., & Vořechovský, I. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky389 · Cited by 54
Polycystic kidney disease: novel insights into polycystin function
Luo, L., Roy, S., Li, L., & Ma, M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.01.005 · Cited by 54
Lanktree, M. B., Iliuta, I.-A., Haghighi, A., Song, X., & Pei, Y. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy261 · Cited by 54
Self-citationClaus, L. R., Chen, C., Stallworth, J. L., Turner, J. L., Slaats, G. G. G., Hawks, A. L., Mabillard, H. R., Senum, S. R., Srikanth, S., Flanagan‐Steet, H. R., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.07.021 · Cited by 53
Griffiths, J., Mills, M. T., & Ong, A. C. M. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032620 · Cited by 53
Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia
Nieuwenhove, E. V., Barber, J. S., Neumann, J., Smeets, E., Willemsen, M., Pasciuto, E., Prezzemolo, T., Lagou, V., Seldeslachts, L., Malengier‐Devlies, B., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.034 · Cited by 52
Regulation of polycystin expression, maturation and trafficking
Hu, J., & Harris, P. C. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109630 · Cited by 51
Sicking, M., Lang, S., Bochen, F., Roos, A., Drenth, J. P. H., Zakaria, M., Zimmermann, R., & Linxweiler, M. (2021) · Cells · doi:10.3390/cells10051036 · Cited by 50
Mantovani, V., Bin, S., Graziano, C., Capelli, I., Minardi, R., Aiello, V., Ambrosini, E., Cristalli, C. P., Mattiaccio, A., Pariali, M., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00464 · Cited by 49
Schönauer, R. A.-R., Baatz, S., Nemitz‐Kliemchen, M., Frank, V., Petzold, F., Sewerin, S., Popp, B., Münch, J., Neuber, S., Bergmann, C., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0816-3 · Cited by 48
Genetics and mechanisms of hepatic cystogenesis
van de Laarschot, L. F. M., & Drenth, J. P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.003 · Cited by 48
Hogan, M. C., Chamberlin, J. A., Vaughan, L. E., Waits, A. L., Banks, C. J., Leistikow, K., Oftsie, T., Madsen, C. D., Edwards, M. E., Glockner, J. F., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13661119 · Cited by 48
Self-citationMolecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease
Cordido, A., Vizoso-González, M., & García-González, M. Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126523 · Cited by 44
Gall, É. C.-L., Chebib, F. T., Madsen, C. D., Senum, S. R., Heyer, C. M., Lanpher, B. C., Patterson, M. C., Albright, R. C., Yu, A. S. L., Torres, V. E., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.11.015 · Cited by 43
Self-citationSETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer
Rao, H., Liu, C., Wang, A., Ma, C., Xu, Y., Ye, T., Su, W., Zhou, P., Gao, W., Li, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43378-w · Cited by 43
Polycystic Liver Disease: Advances in Understanding and Treatment
Masyuk, T. V., Masyuk, A. I., & LaRusso, N. F. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-121247 · Cited by 43
Apple, B. J., Sartori, G., Moore, B. S., Chintam, K., Singh, G., Mohan, P., Strande, N. T., Mirshahi, T., Triffo, W. J., & Chang, A. R. (2022) · Kidney International · doi:10.1016/j.kint.2022.11.025 · Cited by 42
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease
Olaizola, P., Rodrigues, P. M., Caballero-Camino, F. J., Izquierdo‐Sánchez, L., Aspichueta, P., Bujanda, L., LaRusso, N. F., Drenth, J. P. H., Perugorria, M. J., & Bañales, J. M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00617-7 · Cited by 41
Targeting chloride transport in autosomal dominant polycystic kidney disease
Jouret, F., & Devuyst, O. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109703 · Cited by 40
Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes
Yang, H., Sieben, C. J., Schauer, R. S., & Harris, P. C. (2023) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2023.04.004 · Cited by 39
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
Norcia, L. F., Watanabe, E. M., Filho, P. T. H., Hasimoto, C. N., Pelafsky, L., de Oliveira, W. K., & Sassaki, L. Y. (2022) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s377530 · Cited by 38
Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation
Maser, R. L., & Calvet, J. P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109637 · Cited by 38
Genetics of polycystic liver diseases
Lee, P. Y., van de Laarschot, L. F. M., Bañales, J. M., & Drenth, J. P. H. (2019) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000514 · Cited by 38
Chemical‐Synthesis‐Based Approach to Glycoprotein Functions in the Endoplasmic Reticulum
Ito, Y., Kajihara, Y., & Takeda, Y. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202004158 · Cited by 38
Lefèvre, S., Audrézet, M., Halimi, J., Longuet, H., Bridoux, F., Écotière, L., Augusto, J., Duveau, A., Renaudineau, E., Vigneau, C. M., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac027 · Cited by 35
The evolving genetic landscape of congenital disorders of glycosylation
Wilson, M. P., & Matthijs, G. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129976 · Cited by 35
Molecular diagnosis of autosomal dominant polycystic kidney disease
Song, X., Haghighi, A., Iliuta, I.-A., & Pei, Y. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1358088 · Cited by 33
Self-citationTirincsi, A., Sicking, M., Hadzibeganovic, D., Haßdenteufel, S., & Lang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010143 · Cited by 32
The GPCR properties of polycystin-1- A new paradigm
Maser, R. L., Calvet, J. P., & Parnell, S. C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1035507 · Cited by 31
Lang, S., Nguyen, D. Q., Bhadra, P., Jung, M., Helms, V., & Zimmermann, R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.833540 · Cited by 29
Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county
Suwabe, T., Chamberlain, A. M., Killian, J. M., King, B. F., Gregory, A., Madsen, C. D., Wang, X., Kline, T. L., Chebib, F. T., Hogan, M. C., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100166 · Cited by 29
Self-citationA noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family
Besse, W., Choi, J., Ahram, D. F., Mane, S., Sanna‐Cherchi, S., Torres, V. E., & Somlo, S. (2018) · Human Mutation · doi:10.1002/humu.23383 · Cited by 28
Self-citationShan, D., Rezonzew, G., Mullen, S., Roye, R., Zhou, J., Chumley, P. H., Revell, D. Z., Challa, A. K., Kim, H., Lockhart, M. E., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00181.2018 · Cited by 28
A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology
Aron, A. W., Dahl, N. K., & Besse, W. (2022) · Kidney360 · doi:10.34067/kid.0007552021 · Cited by 27
Self-citationWaddell, S. H., Yao, Y., Olaizola, P., Walker, A., Jarman, E. J., Gournopanos, K., Grãdinaru, A., Christodoulou, E., Gautier, P. E., Boerrigter, M. M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq5930 · Cited by 27
Polycystic liver disease genes: Practical considerations for genetic testing
Boerrigter, M. M., Bongers, E. M. H. F., Lugtenberg, D., Nevens, F., & Drenth, J. P. H. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104160 · Cited by 27
Novel GANAB variants associated with polycystic liver disease
van de Laarschot, L. F. M., Morsche, R. H. M. T., Hoischen, A., Venselaar, H., Roelofs, H. M. J., Cnossen, W. R., Bañales, J. M., Roepman, R., & Drenth, J. P. H. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01585-4 · Cited by 26
Use of patient derived urine renal epithelial cells to confirm pathogenicity of PKHD1 alleles
Molinari, E., Srivastava, S., Dewhurst, R. M., & Sayer, J. A. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02094-z · Cited by 26
17q12 Recurrent Deletion Syndrome
Mitchel, M. W., Moreno‐De‐Luca, D., Myers, S. M., Levy, R. V., Turner, S., Ledbetter, D. H., & Martin, C. L. (2020) · Europe PMC (PubMed Central) · Cited by 25
Santos‐Laso, Á., Izquierdo‐Sánchez, L., Rodrigues, P. M., Huang, B. Q., Azkargorta, M., Lapitz, A., Muñoz-Garrido, P., Arbelaiz, A., Caballero-Camino, F. J., Fernández‐Barrena, M. G., et al. (2020) · Liver International · doi:10.1111/liv.14485 · Cited by 25
Pisarello, M. J. L., Masyuk, T. V., Gradilone, S. A., Masyuk, A. I., Ding, J., Lee, P. Y., & LaRusso, N. F. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.12.016 · Cited by 25
Molecular genetics of renal ciliopathies
Barroso‐Gil, M., Olinger, E. G., & Sayer, J. A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200791 · Cited by 25
An update on ductal plate malformations and fibropolycystic diseases of the liver
Mirza, H., Besse, W., Somlo, S., Weinreb, J. C., Kenney, B. C., & Jain, D. (2022) · Human Pathology · doi:10.1016/j.humpath.2022.06.022 · Cited by 25
Self-citationSignal sequences encode information for protein folding in the endoplasmic reticulum
Sun, S., Li, X., & Mariappan, M. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202203070 · Cited by 25
Mahboobipour, A. A., Ala, M., Lord, J. S., & Yaghoobi, A. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03187-w · Cited by 24
Krappitz, M., Bhardwaj, R., Dong, K., Staudner, T., Yılmaz, D. E., Pioppini, C., Westergerling, P., Ruemmele, D., Hollmann, T., Nguyen, T. A., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021091180 · Cited by 21
Self-citationWaldrop, E., Al-Obaide, M. A. I., & Vasylyeva, T. L. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00044 · Cited by 21
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Exploring the Spectrum of Kidney Ciliopathies
Santoni, M., Piva, F., Cimadamore, A., Giulietti, M., Battelli, N., Montironi, R., Cosmai, L., & Porta, C. (2020) · Diagnostics · doi:10.3390/diagnostics10121099 · Cited by 19
Polycystic liver disease: The interplay of genes causative for hepatic and renal cystogenesis
Masyuk, T. V., Masyuk, A. I., & LaRusso, N. F. (2018) · Hepatology · doi:10.1002/hep.29708 · Cited by 18
Boulogne, F., Claus, L. R., Wiersma, H. H., Oelen, R., Schukking, F., de Klein, N., Li, S., Westra, H.-J., van der Zwaag, B., van Reekum, F. E., et al. (2023) · European Journal of Human Genetics · doi:10.1038/s41431-023-01296-x · Cited by 18
Self-citationPathway identification through transcriptome analysis
Terabayashi, T., Germino, G. G., & Menezes, L. F. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109701 · Cited by 18
Jawaid, T., Elbarougy, D. E., Lavu, S., Buia, G., Senum, S. R., Olinger, E. G., Yang, H., McDonnell, S. K., Bublitz, J. T., Ma, J., et al. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000613 · Cited by 18
Self-citationWilson, M. P., Garanto, A., Vairo, F. P. E., Ng, B. G., Ranatunga, W. K., Ventouratou, M., Baerenfaenger, M., Huijben, K., Thiel, C., Ashikov, A., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.09.012 · Cited by 17
Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management
Hanna, C., Iliuta, I.-A., Besse, W., Mekahli, D., & Chebib, F. T. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151434 · Cited by 17
Self-citationBarten, T. R. M., Bernts, L. H. P., Drenth, J. P. H., & Gevers, T. J. G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1751818 · Cited by 17
Autosomal dominant polycystic kidney disease
Ong, A. C. M., Carriazo, S. M., Mingyao, B., Torrá, R., & Pei, Y. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00046-2 · Cited by 16
Self-citationNovel causative genes for polycystic liver disease
Perugorria, M. J., & Bañales, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.69 · Cited by 16
Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney Disease
Gulati, A., Dahl, N. K., Hartung, E. A., Clark, S. L., Moudgil, A., Goodwin, J. E., & Somlo, S. (2023) · Kidney360 · doi:10.34067/kid.0000000000000064 · Cited by 15
Self-citationSierks, D., Schönauer, R. A.-R., Friedrich, A., Hantmann, E., de Fallois, J., Linder, N., Fischer, J., Herber, A., Bergmann, C., Berg, T., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100579 · Cited by 15
Zagorec, N., Calamel, A., Delaporte, M., Olinger, E. G., Orr, S. E., Sayer, J. A., Pillay, V.-G., Denommé‐Pichon, A., Mau‐Them, F. T., Nambot, S., et al. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2024.10.009 · Cited by 15
Roy, K., & Marin, E. P. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4224-6 · Cited by 15
Ji, R., Chen, J., Xie, Y., Dou, X., Qing, B., Liu, Z., Lu, Y., Dang, L., Zhu, X., Sun, Y., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.12.033 · Cited by 15
Hawelka, B., Hammerl, M., & Gruber, H. G. (2007) · Cited by 15
Sadeghi‐Alavijeh, O., Chan, M., Doctor, G. T., Voinescu, C., Stuckey, A., Kousathanas, A., Ho, A. T., Stanescu, H. C., Stanescu, H., Sandford, R., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci181467 · Cited by 14
Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling
Wills, E. S., Morsche, R. H. M. T., van Reeuwijk, J., Horn, N., Geomini, I., van de Laarschot, L. F. M., Mans, D. A., Ueffing, M., Boldt, K., Drenth, J. P. H., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx308 · Cited by 14
Arjune, S., Todorova, P., Bartram, M. P., Grundmann, F., & Müller, R. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae363 · Cited by 14
Devuyst, O., & Pei, Y. (2020) · Kidney International · doi:10.1016/j.kint.2019.11.019 · Cited by 14
Self-citationLarge Deletions in GANAB and SEC63 explain 2 cases of polycystic kidney and liver disease
Wilson, E. M., Choi, J., Torres, V. E., Somlo, S., & Besse, W. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.01.009 · Cited by 13
Self-citationAdult Inactivation of the Recessive Polycystic Kidney Disease Gene Causes Polycystic Liver Disease
Besse, W., Roosendaal, C., Tuccillo, L., Roy, S. G., Gallagher, A., & Somlo, S. (2020) · Kidney360 · doi:10.34067/kid.0002522020 · Cited by 13
Self-citationNOTCH signalling – a core regulator of bile duct disease?
Lyons, A. M., & Boulter, L. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050231 · Cited by 12
SEC61B regulates calcium flux and platelet hyperreactivity in diabetes
Kong, Y. X., Rehan, R., Moreno, C. L., Madsen, S., Zhang, Y., Zhao, H., Qi, M., Houlahan, C. B., Cartland, S. P., Robertshaw, D., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184597 · Cited by 12
Metadata
- Authors
- Besse, W., Dong, K., Choi, J., Punia, S., Fedeles, S. V., Choi, M., Gallagher, A.-R., Huang, E. B., Gulati, A., Knight, J., Mane, S., Tahvanainen, E., Tahvanainen, P., Sanna-Cherchi, S., Lifton, R. P., Watnick, T., Pei, Y. P., Torres, V. E., & Somlo, S.
- Affiliations
- Yale University (US)
- University of Helsinki (FI)
- University of Maryland, Baltimore (US)
- University Health Network (CA)
- Mayo Clinic (US)
- Corresponding author
- Somlo, Stefan
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-04-04
- Volume
- 127
- Issue
- 5
- Pages
- 1772-1785
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5409105
- OpenAlex
- W2605235307
- Cited by
- 203
- References
- 69
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 17 · 2023: 38 · 2022: 25 · 2021: 21 · 2020: 30 · 2019: 13 · 2018: 14 · 2017: 13
- FWCI
- 12.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (DK090728)
- Yale University
- PKD Australia
- National Institutes of Health (NIH U54, DK090728, UL1TR001863)
- National Human Genome Research Institute (U54HG006504, UM1HG006504)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100592, R01DK054053, R01DK103184, P30DK090868, R01DK051041, T32DK007276, P30DK079310, R01DK044863, P30DK090728)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- polycystin-1, ALG8, GANAB, PRKCSH, SEC63, PKHD1, autosomal recessive polycystic kidney disease, loss-of-function mutations, liver cysts, genetic heterogeneity
- MeSH terms
- SEC Translocation Channels, Adult, Animals, Calcium-Binding Proteins, Cell Line, Transformed, Cysts, Endoplasmic Reticulum, Female, Glucosidases, Glucosyltransferases, Heterozygote, Humans, Liver Diseases, Male, Membrane Proteins, Mutation, RNA-Binding Proteins, Molecular Chaperones, Intracellular Signaling Peptides and Proteins, TRPP Cation Channels, Mice, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.